The latest report by IMARC Group, titled “Isothermal Nucleic Acid Amplification Technology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032“, The global isothermal nucleic acid amplification technology (INAAT) market size reached US$ 3.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.9 Billion by 2032, exhibiting a growth rate (CAGR) of 10.8% during 2024-2032.
Isothermal nucleic acid amplification technology, unlike traditional methods, enables the amplification of DNA or RNA sequences at a constant temperature. It is increasingly recognized in diagnostics, particularly for detecting infectious pathogens using nucleic acids as biomarkers. This approach offers simplicity, speed, and cost-effectiveness, ideal for point-of-care (POC) diagnostics, notably in resource-limited settings. Techniques encompass loop-mediated isothermal amplification (LAMP), nucleic acid sequence-based amplification (NASBA), strand displacement amplification (SDA), rolling circle amplification (RCA), and recombinase polymerase amplification (RPA). Noteworthy advantages include miniaturized sensors, in situ diagnosis capability, and alignment with the World Health Organization’s ASSURED criteria, enhancing their value for rapid and precise molecular diagnostics.
For an in-depth analysis, you can refer sample copy of the report:https://www.imarcgroup.com/isothermal-nucleic-acid-amplification-technology-market/requestsample
Isothermal Nucleic Acid Amplification Technology Market Trends and Drivers:
The burgeoning global market for isothermal nucleic acid amplification technology is primarily fueled by the escalating need for swift and precise molecular diagnostics. Isothermal amplification techniques offer significant advantages compared to conventional PCR, as they can amplify nucleic acids consistently at a fixed temperature, obviating the requirement for costly thermal cyclers and intricate laboratory setups. This feature makes them particularly appealing in regions with limited resources and infrastructural capabilities for sophisticated molecular diagnostics. Additionally, the increasing incidence of infectious diseases, spanning viral, bacterial, and parasitic origins, is spurring the demand for effective and accessible diagnostic solutions, constituting another pivotal driver for market expansion. Moreover, isothermal nucleic acid amplification methods exhibit promising prospects in detecting infectious pathogens, facilitating prompt and accurate diagnoses, thereby bolstering market growth. Renowned for their high sensitivity and specificity, these methods enable the detection of targets with minimal false-positive or false-negative outcomes. Furthermore, the capability to conduct swift on-site diagnostics utilizing isothermal amplification technology enhances patient care, infection management, and disease surveillance, further propelling market advancement. Furthermore, the growing emphasis on personalized medicine and precision diagnostics is amplifying the need for sophisticated molecular technologies, enabling the identification of specific genetic variations or mutations linked to diverse ailments, thereby fostering a favorable market trajectory.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product:
- Instruments
- Reagents
Breakup by Technology:
- Helicase-Dependent Amplification (HDA)
- Nicking Enzyme Amplification Reaction (NEAR)
- Loop-Mediated Isothermal Amplification (LAMP)
- Strand Displacement Amplification (SDA)
- Nucleic Acid Sequence-Based Amplification (NASBA)
- Transcription Mediated Amplification (TMA)
- Single Primer Isothermal Amplification (SPIA)
- Others
Breakup by Application:
- Infectious Disease Diagnosis
- Hepatitis
- CT/NG
- HIV
- Influenza
- Others
- Blood Screening
- Others
Breakup by End-User:
- Hospitals
- Diagnostic Laboratories
- Research Laboratories
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Abbott Laboratories
- bioMérieux SA
- Becton
- Dickinson and Company
- Eiken Chemical Co. Ltd.
- Hologic Inc., Meridian Bioscience Inc.
- OptiGene Limited
- Thermo Fisher Scientific Inc.
- Tecan Trading AG
- Ustar Biotechnologies Ltd.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 |United Kingdom: +44-753-713-2163
